Most cited papers in Drug-Induced Ocular Toxicity
What are the most cited papers in Drug-Induced Ocular Toxicity?
The most cited paper in Drug-Induced Ocular Toxicity is "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology" (Eva Vanessa Schrezenmeier, Thomas Dörner, 2020), with 1,519 citations. Next come "Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients" (1,440) and "Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)" (1,287).
Showing 50 of 99 papers. Every paper with more than 290 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology Eva Vanessa Schrezenmeier, Thomas Dörner · Nature Reviews Rheumatology | 7 Feb 2020 | 1,519 |
| 2 | Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients Zhixiang Shen, Guoqiang Chen, Jian-Hua Ni et al. · Blood | May 1997 | 1,440 |
| 3 | Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid) Raymond P. Warrell, Stanley R. Frankel, Wilson H. Miller et al. · New England Journal of Medicine | 16 May 1991 | 1,287 |
| 4 | Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China Ping Wu, Fang Duan, Chunhua Luo et al. · JAMA Ophthalmology | 31 Mar 2020 | 1,285 |
| 5 | All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments] Sylvie Castaigné, Christine Chomienne, MT Daniel et al. · Blood | Nov 1990 | 1,205 |
| 6 | Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision) Michael F. Marmor, Ulrich Kellner, Timothy Y. Y. Lai et al. · Ophthalmology | 16 Mar 2016 | 1,189 |
| 7 | POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN Abdulrahman Mahgoub, L. Graham Dring, Jeffrey R. Idle et al. · The Lancet | Sep 1977 | 1,189 |
| 8 | All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Martin S. Tallman, Janet W. Andersen, Charles Alan Schiffer et al. · New England Journal of Medicine | 9 Oct 1997 | 1,099 |
| 9 | A Molecular Marker for Chloroquine-Resistant Falciparum Malaria ABDOULAYE A. DJIMDÉ, O K Doumbo, Joseph F. Cortese et al. · New England Journal of Medicine | 25 Jan 2001 | 1,035 |
| 10 | Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review Guillermo Ruiz‐Irastorza, Manuel Ramos‐Casals, Pilar Brito‐Zerón et al. · Annals of the Rheumatic Diseases | 22 Dec 2008 | 990 |
| 11 | ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY Yutaka Imamura, Takamitsu Fujiwara, Ron Margolis et al. · Retina | Nov 2009 | 973 |
| 12 | United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia Steven L. Soignet, Stanley R. Frankel, Dan Douer et al. · Journal of Clinical Oncology | 15 Sep 2001 | 829 |
| 13 | Anti-Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients Josep O. Dalmau, Francesc Graus, Marc k. Rosenblum et al. · Medicine | Mar 1992 | 825 |
| 14 | The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia Stanley R. Frankel, Anna Eardley, Gregory Yves Lauwers et al. · Annals of Internal Medicine | 15 Aug 1992 | 722 |
| 15 | Association of Elevated Serum Lipid Levels With Retinal Hard Exudate in Diabetic Retinopathy Emily Y. Chew · Archives of Ophthalmology | Sep 1996 | 716 |
| 16 | Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy Michael F. Marmor, Ulrich Kellner, Timothy Y. Y. Lai et al. · Ophthalmology | Feb 2011 | 716 |
| 17 | Sensory Neuropathy from Pyridoxine Abuse Herbert H. Schaumburg, Jerry G. Kaplan, Anthony J. Windebank et al. · New England Journal of Medicine | 25 Aug 1983 | 710 |
| 18 | The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy Ronald B. Melles, Michael F. Marmor · JAMA Ophthalmology | 2 Oct 2014 | 696 |
| 19 | Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications James R. O’Dell, Claire E. Haire, Nils Erikson et al. · New England Journal of Medicine | 16 May 1996 | 655 |
| 20 | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Dan Zhou, Sheng‐Ming Dai, Qiang Tong · Journal of Antimicrobial Chemotherapy | 6 Mar 2020 | 631 |
| 21 | Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients Chao Niu et al. · Blood | 15 Nov 1999 | 629 |
| 22 | Hydroxychloroquine: From Malaria to Autoimmunity Ilan Ben‐Zvi, Shaye Kivity, Pnina Langevitz et al. · Clinical Reviews in Allergy & Immunology | 6 Jan 2011 | 623 |
| 23 | The Overexpression of Bax Produces Cell Death upon Induction of the Mitochondrial Permeability Transition John G. Pastorino, Sing-Tsung Chen, Marco Tafani et al. · Journal of Biological Chemistry | Mar 1998 | 587 |
| 24 | New insights into the antiviral effects of chloroquine Andrea Savarino, Livia Di Trani, Isabella Donatelli et al. · The Lancet Infectious Diseases | 27 Jan 2006 | 582 |
| 25 | Trends and mortality effects of vitamin A deficiency in children in 138 low-income and middle-income countries between 1991 and 2013: a pooled analysis of population-based surveys Gretchen A Stevens, James E. Bennett, Quentin Hennocq et al. · The Lancet Global Health | 29 Aug 2015 | 577 |
| 26 | Some puzzling pharmacological effects of monoamine oxidase inhibitors. Joseph Edward Knoll, Kálmán Magyar · PubMed | 1972 | 562 |
| 27 | Of chloroquine and COVID-19 Franck Touret, Xavier Nicolas de Lamballerie · Antiviral Research | 6 Mar 2020 | 559 |
| 28 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases Kim Drummond Rainsford, Ann L. Parke, Matthew Clifford‐Rashotte et al. · Inflammopharmacology | 5 Aug 2015 | 553 |
| 29 | Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · The Lancet Oncology | 14 Sep 2015 | 548 |
| 30 | Hydroxychloroquine in lupus pregnancy Megan E. B. Clowse, Laurence S. Magder, Frank R. Witter et al. · Arthritis & Rheumatism | 30 Oct 2006 | 540 |
| 31 | Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) Graciela S. Alarcón, Gerald McGwin, Ana María Bertoli et al. · Annals of the Rheumatic Diseases | 27 Mar 2007 | 538 |
| 32 | Thalidomide in the treatment of lepra reactions Jacob Sheskin · Clinical Pharmacology & Therapeutics | May 1965 | 534 |
| 33 | Leber hereditary optic neuropathy Patrick Yu Wai Man, D M Turnbull, P F Chinnery · Journal of Medical Genetics | Mar 2002 | 525 |
| 34 | Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group Pierre Fenaux, M-C. Le Deley, Sylvie Castaigné et al. · Blood | Dec 1993 | 521 |
| 35 | Definition of glaucoma: clinical and experimental concepts Robert James Casson, Glyn Chidlow, John P. M. Wood et al. · Clinical and Experimental Ophthalmology | 22 Feb 2012 | 519 |
| 36 | Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme Julio Sotelo, Eduardo Daniel Briceño, Miguel Angel López-González · Annals of Internal Medicine | 7 Mar 2006 | 517 |
| 37 | Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia Guillermo Lazo, Hagop M. Kantarjian, Elihu H. Estey et al. · Cancer | 17 Apr 2003 | 495 |
| 38 | The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation Paul Riordan‐Eva, Michael D. Sanders, G.G. Govan et al. · Brain | 1995 | 491 |
| 39 | Diagnostic Criteria for Graves' Ophthalmopathy George B. Bartley, Colum A. Gorman · American Journal of Ophthalmology | Jun 1995 | 486 |
| 40 | Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema Jost Bruno Jonas, Antje Söfker · American Journal of Ophthalmology | Sep 2001 | 482 |
| 41 | Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases Md. Abdul Alim Al‐Bari · Journal of Antimicrobial Chemotherapy | 17 Feb 2015 | 472 |
| 42 | Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy Aparna Areti, Veera Ganesh Yerra, V.G.M. Naidu et al. · Redox Biology | 2014 | 463 |
| 43 | Paracentral Acute Middle Maculopathy David Sarraf, Ehsan Rahimy, Amani A. Fawzi et al. · JAMA Ophthalmology | 9 Aug 2013 | 463 |
| 44 | A Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa Michael F. Marmor · Archives of Ophthalmology | Nov 1993 | 462 |
| 45 | Pseudoexfoliation Syndrome Ocular Manifestation of a Systemic Disorder? Ursula M. Schlötzer-Schrehardt · Archives of Ophthalmology | Dec 1992 | 443 |
| 46 | Return of Chloroquine Antimalarial Efficacy in Malawi Miriam K. Laufer, Phillip C. Thesing, Nicole D. Eddington et al. · New England Journal of Medicine | 8 Nov 2006 | 442 |
| 47 | Incidence of Nonarteritic Anteripr Ischemic Optic Neuropathy Matthew G. Hattenhauer, Jacqueline A. Leavitt, David O. Hodge et al. · American Journal of Ophthalmology | 1997 | 440 |
| 48 | Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial Anne Katrin Sjølie, Ronald Klein, Massimo Porta et al. · The Lancet | 26 Sep 2008 | 435 |
| 49 | Mechanism of action of hydroxychloroquine as an antirheumatic drug Robert I. Fox · Seminars in Arthritis and Rheumatism | Oct 1993 | 435 |
| 50 | Focal Myocarditis Associated with Pheochromocytoma Peter D. Van Vliet, Howard B. Burchell, Jack L. Titus · New England Journal of Medicine | 19 May 1966 | 430 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.